15.09.2022 • NewsGlobal AminesWilmarClariant

Global Amines Commissions Indonesia Plant

Singapore’s Global Amines – a joint venture between compatriot company Wilmar and Switzerland’s Clariant – has successfully started up a new fatty amines plant in Surabaya, Indonesia.

The plant will supply customers both in southeast Asia and worldwide, supporting the company’s existing facilities in China, Europe and the Americas. The company did not divulge the plant’s annual capacity.

“Supplying our customers with competitive and high-quality fatty amines globally is our essential purpose, particularly with demand growing across markets. Construction and commissioning under the pandemic restrictions was extremely challenging, but we are now very happy to have our new facility on stream to complete our truly global network for fatty amines production,” said group general manager Ernesto Horikoshi. “The substantial new capacity and extended footprint enable us to provide our customers with the stability of reliable and competitive supply for their ever-increasing needs.”

The company added that the plant’s location in the world’s largest integrated oleochemical site enables easy access to key feedstocks, particularly sustainable palm and derivatives certified by the Roundtable on Sustainable Palm Oil.

Global Amines’ new fatty amines production plant in Surabaya, Indonesia ©...
Global Amines’ new fatty amines production plant in Surabaya, Indonesia © Global Amines Company

Fatty amines are used to produce key ingredients in personal care and home care products, such as mild surfactants and co-surfactants for shampoo and dishwashing liquids, and also as raw materials for diverse industrial applications.

Global Amines announced on Aug. 31 that it has agreed to buy Clariant’s quats and esterquats business. The acquisition is expected to close during the first half of next year.

Author: Elaine Burridge, Freelance Journalist

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.